title: Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
abstract: CD10 has been demonstrated to be positive in endometrial stromal sarcoma (ESS) and thus is useful in establishing the diagnosis, but its expression in malignant müllerian mixed tumor (MMMT) and müllerian adenosarcoma remains to be clarified. In this study, 12 cases of MMMT (9 uterine, 2 tubal, and 1 metastatic), 6 cases of müllerian adenosarcoma (three corporeal, two cervical, and one tubal), and 7 cases of primary uterine sarcomas had their tissues examined immunohistochemically for expression of CD10, desmin, myoglobin, alpha-smooth muscle actin (SMA), and cytokeratin. Of the primary uterine sarcomas, two were primary rhabdomyosarcomas (one cervical and one corporeal), two were ESSs, two were high-grade leiomyosarcomas, and one was a high-grade endometrial sarcoma. Sarcomatous components in all cases of MMMT and müllerian adenosarcoma, as well as all uterine sarcomas, were positive for CD10, showing moderate to marked staining intensity with varying distribution except in one MMMT, which showed weak and very focal staining. In four MMMTs, three adenosarcomas, and one rhabdomyosarcoma, myoglobin- and/or desmin-positive rhabdomyoblastic cells were positive for CD10. The immunoreactivity for CD10 showed the same distribution for alpha-SMA and myoglobin in three and two MMMTs, respectively. In five cases of MMMT, carcinomatous components were focally positive for CD10, and in two cases small populations of round or short spindle cells in sarcomatous components were positive for CD10, alpha-SMA, and cytokeratin (CAM5.2). These results indicate that CD10 expression is not restricted to ESS but can be positive in MMMT and müllerian adenosarcoma as well as in a variety of uterine tumors including high-grade leiomyosarcoma and rhabdomyosarcoma. CD10 expression might be one of the characteristics of müllerian system-derived neoplastic mesenchymal cells.
authors.affiliation: Department of Pathology, Kawasaki Medical School Hospital, Kurashiki, Okayama, Japan. mika@med.kawasaki-m.ac.jp
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Mikami
authors.forename: Sakae
authors.initials: S
authors.lastname: Hata
authors.forename: Takako
authors.initials: T
authors.lastname: Kiyokawa
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Manabe
mesh_terms: D018195:Adenosarcoma / Q000378:metabolism*; D016889:Endometrial Neoplasms / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D018200:Mixed Tumor, Mullerian / Q000378:metabolism*; D015260:Neprilysin / Q000096:biosynthesis*; D012208:Rhabdomyosarcoma / Q000378:metabolism; D018203:Sarcoma, Endometrial Stromal / Q000378:metabolism; D014594:Uterine Neoplasms / Q000378:metabolism*
chemical_list: D015260:Neprilysin